Karin Jooss

Insider Reports History

Location: Emeryville, CA
Signature: /s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Company	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Gritstone bio, Inc.	EVP, Head of Research and Development	Common Stock	683,526	$511,483	$0.7483	16 May 2024	Direct
FATE THERAPEUTICS INC	Director	Stock Option (Right to Buy)	55,000	$109,200	$2.73	29 May 2025	Direct
Gritstone bio, Inc.	EVP, Head of Research and Development	Stock Option (Right to Buy)	235,000			15 May 2024	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Role	Filing Time
FATE	FATE THERAPEUTICS INC	29 May 2025	1	$0	4	Director	30 May 2025, 16:08
FATE	FATE THERAPEUTICS INC	07 Jun 2024	1	$0	4	Director	11 Jun 2024, 16:30
/report/000141588924013655-jooss-karin-2024-05-15	Gritstone bio, Inc.	15 May 2024	3	-$10,288	4	EVP, Head of Research and Development	17 May 2024, 21:57
/report/000141588924002714-jooss-karin-2024-02-01	Gritstone bio, Inc.	01 Feb 2024	2	$0	4	EVP, Head of Research and Development	05 Feb 2024, 19:08
FATE	FATE THERAPEUTICS INC	06 Jun 2023	1	$0	4	Director	07 Jun 2023, 16:10
/report/000156761923001947-jooss-karin-2023-02-02	Gritstone bio, Inc.	02 Feb 2023	1	$0	4	Executive Vice President and Head of Research and Development	06 Feb 2023, 16:32
FATE	FATE THERAPEUTICS INC	09 Jun 2022	2	$0	4	Director	13 Jun 2022, 16:41
FATE	FATE THERAPEUTICS INC	03 Jun 2022	1	-$33,842	4	Director	06 Jun 2022, 16:48
/report/000156761922008721-jooss-karin-2022-01-31	Gritstone bio, Inc.	31 Jan 2022	2	$0	4	Executive Vice President and Head of Research and Development	20 Apr 2022, 16:40
FATE	FATE THERAPEUTICS INC	02 Jun 2021	2	$0	4	Director	04 Jun 2021, 17:27
/report/000156761921020867-jooss-karin-2021-01-07	Gritstone bio, Inc.	07 Jan 2021	1	$0	4	Executive Vice President and Chief Scientific Officer	19 Nov 2021, 16:20